Mostrar el registro sencillo del ítem
dc.contributor.author
Garimano, Nicolás Ezequiel

dc.contributor.author
Amaral, María Marta

dc.contributor.author
Ibarra, Cristina Adriana

dc.date.available
2023-07-13T11:08:48Z
dc.date.issued
2020
dc.identifier.citation
A transcellular Gb3 dependent pathway is mainly responsible for Shiga toxin-2 cytotoxicity and translocation across human intestinal epithelial cells infected with E. coli O157:H7.; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología y IX Reunión Anual de la Asociación Argentina de Nanomedicinas; Mar del Plata; Argentina; 2019; 1-5
dc.identifier.uri
http://hdl.handle.net/11336/203627
dc.description.abstract
Shiga toxin-2 (Stx2) is produced and released by E. coli O157:H7 (O157:H7) into the intestinal lumen after colonization, and is able to translocate to the circulatory system and reach target cells causing hemolytic uremic syndrome. Our aim was to elucidate which pathways were involved in Stx2 endocytosis and translocation across intestinal cells infected with STEC. HCT-8 cells grown on 96-well plates were preincubated with specific endocytosis inhibitors such as Eliglustat (EG), Dynasore (DY), MßCD or Amiloride (AM). Then, cells were washed and incubated for 4 h with 100 ng/ml Stx2 alone or in the presence of O157:H7 mutant lacking stx2 gene (O157:H7Ðstx2). Stx2 uptake was measured by flow cytometry and its cytotoxic effect by neutral red uptake assay. Translocation of Stx2 was evaluated by inhibitor preincubation of HCT-8, grown as monolayers on Millicell inserts, and incubated with O157:H7 Ðstx2+ Stx2. Then Stx2 cytotoxicity was quantified in lower chamber media by neutral red uptake, To analyze inhibitors effect on bacteria attachment, bacterial adherence assays were performed on HCT-8 monolayers cultured on 24- wells plates. EG caused the maximum decrease of Stx2 cytotoxic activity, followed by MßCD. AM and DY significantly neutralized Stx2 cytotoxicity but only in presence of O157:H7Ðstx2.Furthermore, Stx2 uptake was reduced when cells were preincubated with EG or MßCD, compared to DY or AM (p<0.05), indicating that Stx2 uptake may depend on Gb3 receptor, and, to a lesser extent, on cholesterol, which is consistent with a necessary interaction between Stx2 and its receptor to cause cytotoxicity. Moreover, both dynamin-dependent endocytosis and Gb3-independent macropinocytosis became relevant only when bacteria were present, suggesting that these mechanisms are sensible to bacterial infection. Taken together, our study suggests that the mechanisms responsible for enhanced cytotoxicity and transcytosis during infection may have the same endocytic origin
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Fundacion Revista Medicina
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
E. coli
dc.subject
SUH
dc.subject
Stx2
dc.subject
Transcytosis
dc.subject.classification
Enfermedades Infecciosas

dc.subject.classification
Ciencias de la Salud

dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD

dc.title
A transcellular Gb3 dependent pathway is mainly responsible for Shiga toxin-2 cytotoxicity and translocation across human intestinal epithelial cells infected with E. coli O157:H7.
dc.type
info:eu-repo/semantics/publishedVersion
dc.type
info:eu-repo/semantics/conferenceObject
dc.type
info:ar-repo/semantics/documento de conferencia
dc.date.updated
2022-11-09T19:13:58Z
dc.journal.volume
79
dc.journal.pagination
1-5
dc.journal.pais
Argentina

dc.journal.ciudad
Buenos Aires
dc.description.fil
Fil: Garimano, Nicolás Ezequiel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina
dc.description.fil
Fil: Amaral, María Marta. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina
dc.description.fil
Fil: Ibarra, Cristina Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.medicinabuenosaires.com/indices-de-2010-a-2019/
dc.conicet.rol
Autor

dc.conicet.rol
Autor

dc.conicet.rol
Autor

dc.coverage
Nacional
dc.type.subtype
Reunión
dc.description.nombreEvento
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología y IX Reunión Anual de la Asociación Argentina de Nanomedicinas
dc.date.evento
2019-11-13
dc.description.ciudadEvento
Mar del Plata
dc.description.paisEvento
Argentina

dc.type.publicacion
Journal
dc.description.institucionOrganizadora
Sociedad Argentina de Investigación Clínica
dc.description.institucionOrganizadora
Asociación Argentina de Farmacología Experimental
dc.description.institucionOrganizadora
Sociedad Argentina de Biología
dc.description.institucionOrganizadora
Sociedad Argentina de Protozoología
dc.description.institucionOrganizadora
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
dc.description.institucionOrganizadora
Asociación Argentina de Nanomedicinas
dc.source.revista
Medicina (Buenos Aires)

dc.date.eventoHasta
2019-11-16
dc.type
Reunión
Archivos asociados